Form 10-Q Organogenesis Holdings For: Sep 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Wall St rises as oil slide offers respite after Fed rate hike
- Oil falls 2% to one-week low as Middle East supply disruption fears ease
- The Fed is hiking. Why isn't UBS worried about stocks?
- Wall Street on Fed rate hike: 'As hawkish as it gets'
- RBC bullish on Kraft Heinz, sees return to growth in 2027
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Shipping stocks on fire — but cracks are forming in the rate rally
- JPMorgan Fed scenario analysis: 5 paths for the S&P 500 today
- Paradium AI (PAAI) Halted, News Pending
Oranogenesis Holdings (ORGO) PT Raised to $3.80 at Cantor Fitzgerald
November 13, 2024 7:16 AM ESTCantor Fitzgerald analyst Ross Osborn raised the price target on Oranogenesis Holdings (NASDAQ: ORGO) to $3.80 (from $3.50) while maintaining a Overweight rating.
The analyst comments "We reiterate our Overweight and increase our 12-month price target to $3.80 from $3.50 on Organogenesis' ("ORGO") shares following the... More
